FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

AbbVie Duopa Recall

Duopa (carbidopa and levodopa enteral suspension), 4

AbbVie Inc. · North Chicago, IL

Risk level
Class II
Reported by FDA
Mar 8, 2017
Recall ID
D-0495-2017
Check your lot numberHow we source this data

Summary

AbbVie recalled Duopa starting Jan 13, 2017. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0495-2017 on Mar 8, 2017. Reason: Failed Stability Specifications: confirmed out of specification results obtained during refrigerated material stability testing indicating that drug may settle within drug cassettes nearing the end of their refrigerated shelf-life. Status: Terminated.

Why it was recalled

Failed Stability Specifications: confirmed out of specification results obtained during refrigerated material stability testing indicating that drug may settle within drug cassettes nearing the end of their refrigerated shelf-life

Product description

Duopa (carbidopa and levodopa enteral suspension), 4.63 mg/20 mg per mL, 100 mL cassette, 7 cassettes per carton, Rx Only, AbbVie Inc., North Chicago, IL 60064 --- NDC 0074-3012-07

Lot numbers, UPCs & expiration codes

Lots: 1055692, Expiration Date (Frozen) 06/01/2018 1057881, Expiration Date (Frozen) 06/02/2018 1060138, Expiration Date (Frozen) 06/13/2018 1060140, Expiration Date (Frozen) 06/15/2018 1061258, Expiration Date (Frozen) 06/17/2018 1061262, Expiration Date (Frozen) 06/30/2018 1063033, Expiration Date (Frozen) 07/14/2018

Where it was sold

TN and IL

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0495-2017
Classification
Class II
Status
Terminated
Recall initiated
Jan 13, 2017
FDA report date
Mar 8, 2017
Quantity
4021 cartons, 7 100-mL cassettes each
Recall type
Voluntary: Firm initiated
Recalling firm
AbbVie Inc.

Original FDA data

Every field from FDA enforcement report D-0495-2017, exactly as published.

Show all FDA fields
City
North Chicago
State
IL
Status
Terminated
Country
United States
Event ID
76199
Address
1 N Waukegan Rd
Code information
Lots: 1055692, Expiration Date (Frozen) 06/01/2018 1057881, Expiration Date (Frozen) 06/02/2018 1060138, Expiration Date (Frozen) 06/13/2018 1060140, Expiration Date (Frozen) 06/15/2018 1061258, Expiration Date (Frozen) 06/17/2018 1061262, Expiration Date (Frozen) 06/30/2018 1063033, Expiration Date (Frozen) 07/14/2018
Postal code
60064-1802
Report date
Mar 8, 2017
Product type
Drugs
Recall number
D-0495-2017
Classification
Class II
Recalling firm
AbbVie Inc.
Product quantity
4021 cartons, 7 100-mL cassettes each
Termination date
Mar 15, 2019
Reason for recall
Failed Stability Specifications: confirmed out of specification results obtained during refrigerated material stability testing indicating that drug may settle within drug cassettes nearing the end of their refrigerated shelf-life
Voluntary / mandated
Voluntary: Firm initiated
Product description
Duopa (carbidopa and levodopa enteral suspension), 4.63 mg/20 mg per mL, 100 mL cassette, 7 cassettes per carton, Rx Only, AbbVie Inc., North Chicago, IL 60064 --- NDC 0074-3012-07
Distribution pattern
TN and IL
Recall initiation date
Jan 13, 2017
Initial firm notification
E-Mail
Center classification date
Feb 27, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0495-2017, published Mar 8, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls